The ESMO Colloquia are innovative new sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the congress.
Sunday, 10 September
ESMO Colloquium:Systemic Treatment of Unresectable Hepatocellular Carcinoma
Room:Sevilla Auditorium, 13:00-14:30
This educational activity is provided by ESMO and supported by Eisai.
View the ESMO colloquium details
Learning Objectives
- Awareness of the increased incidence of the disease and the etiology
- Management of patients with unresectable HCC using systemic treatment in 1st-line
- New drugs in development and multi-line approach
Monday, 11 September
ESMO Colloquium: Rationale for Chemo-immunotherapy Combination Treatment in Solid Tumours
Room:Granada Auditorium, 13:00-14:30
Identifying the optimal chemotherapy partner for immune checkpoint inhibitors
View the ESMO colloquium details
Learning Objectives
- Understand and optimise the interactions between chemotherapy and the immune mechanisms
- Select the best cytotoxics based on their impact on the immune reaction
- Take advantage of epigenetic alteration to modulate the efficacy of immunotherapy
